Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	0.66	59.82	59.43
Graham Fair Price	-15.55	10.90	12.91
PEG	-28.18	-0.93	-0.72
Price/Book	-7.54	4.23	4.57
Price/Cash Flow	-84.65	50.87	331.39
Prices/Earnings	27.79	25.64	20.07
Price/Sales	-7.86	15.23	16.53
Price/FCF	-84.65	50.87	331.39
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-2.88	0.64	0.66
Operating Margin	-10.38	0.22	0.24
ROA	-41.10	0.02	0.03
ROE	0.06	0.04	-27.64
ROIC	0.04	0.03	-32.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	1.63	0.65	149.51
Dividends QOQ	< 0.005	0.02	881.91
EBIT QOQ	-0.27	-0.11	59.72
EPS QOQ	-0.28	-0.28	0.31
FCF QOQ	-0.71	4.96	594.02
Revenue QOQ	-0.13	< 0.005	94.56
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	65.65	60.90	-7.24
Days Sales Outstanding (DSO)	58.82	60.72	3.23
Inventory Turnover	1.37	1.48	7.81
Debt/Capitalization	0.21	0.41	101.84
Quick Ratio	1.12	0.70	-37.51
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	11.41	11.32	-0.73
Cash	6.47	4.83	-25.30
Capex	-0.04	-0.04	0.86
Free Cash Flow	0.16	0.94	498.00
Revenue	3.15	3.14	-0.38
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.27	0.80	-37.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.47	6.48	1294.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating